Cormorant Asset Management, LP
Top Portfolio Positions
34 positions ·
$1,437,701,395 total
· as of Sep 30, 2025
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| BBOT |
BridgeBio Oncology Therapeutics, Inc.
Healthcare
|
17,878,594 | $207,034,118 | 14.40% | |
| ABVX |
Abivax S.A.
Healthcare
|
1,950,000 | $165,555,000 | 11.52% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
8,325,000 | $118,548,000 | 8.25% | |
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
3,192,521 | $94,817,873 | 6.60% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
1,400,000 | $72,716,000 | 5.06% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
4,010,000 | $65,042,200 | 4.52% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
1,059,331 | $64,259,018 | 4.47% | |
| ACLX |
Arcellx, Inc.
Healthcare
|
775,000 | $63,627,500 | 4.43% | |
| INSM |
INSMED Inc
Healthcare
|
430,000 | $61,924,300 | 4.31% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
2,175,000 | $61,857,000 | 4.30% |
Portfolio Trend
23 quarters · across all stocks
No Holdings History
No holdings records found for this institution in HLXC.